EDNRB and congestive heart failure: These agents included the earliest mixed ETA/ETB antagonist bosentan and others with differential ETA/ETB specificity.372 Short-term administration of bosentan did show beneficial hemodynamic changes in chronic heart failure patients.373 However, the following clinical trials were disappointing.